View Future GrowthDigicann Ventures 과거 순이익 실적과거 기준 점검 2/6Digicann Ventures은 연평균 56.3%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 연평균 8.2%의 비율로 증가했습니다. 매출은 연평균 36.9%의 비율로 감소했습니다.핵심 정보56.35%순이익 성장률73.76%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률7.33%매출 성장률-36.91%자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Sep 2024최근 과거 실적 업데이트Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: CA$0.11 (vs CA$0.87 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.11 (up from CA$0.87 loss in 3Q 2022). Revenue: CA$113.7k (down 34% from 3Q 2022). Net income: CA$880.0k (up CA$3.25m from 3Q 2022).Reported Earnings • Sep 03Second quarter 2023 earnings released: EPS: CA$0.60 (vs CA$4.16 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0.60 (up from CA$4.16 loss in 2Q 2022). Revenue: CA$142.8k (up 4.1% from 2Q 2022). Net income: CA$3.64m (up CA$7.75m from 2Q 2022).모든 업데이트 보기Recent updates공고 • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.공고 • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.공고 • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.공고 • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.New Risk • May 02New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (91% average weekly change). Negative equity (-CA$620k). Shareholders have been substantially diluted in the past year (298% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (€295.1k market cap, or US$315.8k). Minor Risk Large one-off items impacting financial results.Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: CA$0.11 (vs CA$0.87 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.11 (up from CA$0.87 loss in 3Q 2022). Revenue: CA$113.7k (down 34% from 3Q 2022). Net income: CA$880.0k (up CA$3.25m from 3Q 2022).공고 • Oct 24An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc. (CNSX:DCNN) for €0.5 million recently.An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc. (CNSX:DCNN) for €0.5 million recently on October 23, 2023. This transaction is governed exclusively by the laws of Germany subject to the exclusion of German conflicts of laws rules (IPR).Reported Earnings • Sep 03Second quarter 2023 earnings released: EPS: CA$0.60 (vs CA$4.16 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0.60 (up from CA$4.16 loss in 2Q 2022). Revenue: CA$142.8k (up 4.1% from 2Q 2022). Net income: CA$3.64m (up CA$7.75m from 2Q 2022).매출 및 비용 세부 내역Digicann Ventures가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이MUN:VY3 매출, 비용 및 순이익 (CAD Millions)날짜매출순이익일반관리비연구개발비30 Sep 240131030 Jun 240131031 Mar 240151031 Dec 230151030 Sep 230-181030 Jun 230-192031 Mar 230-232031 Dec 220-202030 Sep 22103030 Jun 22113031 Mar 221-14031 Dec 211-15030 Sep 211-838030 Jun 211-8811031 Mar 211-9115031 Dec 201-10318130 Sep 201-6614-1130 Jun 201-9847131 Mar 200-10454131 Dec 190-10156030 Sep 190-57551230 Jun 190-2119031 Mar 190-108031 Dec 180-65030 Sep 180-66030 Jun 180-55031 Mar 180-44031 Dec 170-22030 Sep 170-21030 Jun 170-31031 Mar 170-21031 Dec 160-21030 Sep 160-11030 Jun 160-11031 Mar 160-11031 Dec 150-11030 Sep 150-11030 Jun 150-11031 Mar 150-11031 Dec 140-11030 Sep 140-31030 Jun 140-31031 Mar 140-210양질의 수익: VY3는 CA$14.6M 규모의 큰 일회성 이익이 있어 30th September, 2024까지 지난 12개월 재무 결과에 영향을 미쳤습니다.이익 마진 증가: VY3는 과거에 흑자전환했습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: VY3는 지난 5년 동안 흑자전환하며 연평균 56.3%의 수익 성장을 기록했습니다.성장 가속화: VY3는 지난해 흑자전환하여 5년 평균과 수익 성장률을 비교하기 어렵습니다.수익 대 산업: VY3는 지난해 흑자전환하여 지난 해 수익 성장률을 Pharmaceuticals 업계(12%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: VY3의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/12/28 16:43종가2024/09/30 00:00수익2024/09/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Digicann Ventures Inc.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Siddharth RajeevFundamental Research Corp.
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: CA$0.11 (vs CA$0.87 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.11 (up from CA$0.87 loss in 3Q 2022). Revenue: CA$113.7k (down 34% from 3Q 2022). Net income: CA$880.0k (up CA$3.25m from 3Q 2022).
Reported Earnings • Sep 03Second quarter 2023 earnings released: EPS: CA$0.60 (vs CA$4.16 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0.60 (up from CA$4.16 loss in 2Q 2022). Revenue: CA$142.8k (up 4.1% from 2Q 2022). Net income: CA$3.64m (up CA$7.75m from 2Q 2022).
공고 • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.
공고 • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.
공고 • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.
공고 • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.
New Risk • May 02New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (91% average weekly change). Negative equity (-CA$620k). Shareholders have been substantially diluted in the past year (298% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (€295.1k market cap, or US$315.8k). Minor Risk Large one-off items impacting financial results.
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: CA$0.11 (vs CA$0.87 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.11 (up from CA$0.87 loss in 3Q 2022). Revenue: CA$113.7k (down 34% from 3Q 2022). Net income: CA$880.0k (up CA$3.25m from 3Q 2022).
공고 • Oct 24An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc. (CNSX:DCNN) for €0.5 million recently.An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc. (CNSX:DCNN) for €0.5 million recently on October 23, 2023. This transaction is governed exclusively by the laws of Germany subject to the exclusion of German conflicts of laws rules (IPR).
Reported Earnings • Sep 03Second quarter 2023 earnings released: EPS: CA$0.60 (vs CA$4.16 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0.60 (up from CA$4.16 loss in 2Q 2022). Revenue: CA$142.8k (up 4.1% from 2Q 2022). Net income: CA$3.64m (up CA$7.75m from 2Q 2022).